Empagliflozin
Prediabetic State
The University of Texas Health Science Center at San AntonioSmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 64/ 100
- Competitive Position
- 81/ 100
Competitive context
14 Active assets in the Prediabetic State cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Letrozole The University of Texas Health Science Center at San Antonio | Phase 4 | BB |
Genotropin Columbia University | Phase 4 | BB |
MELATONIN Brigham and Women's Hospital | Phase 3 | B |
Linagliptin Universidad de Guanajuato | Phase 3 | CCC |
Chloroquine Washington University School of Medicine | Phase 2 | CCC |
View all 20 →
Same molecule, other indications
Empagliflozin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →